Fintel reports that on October 21, 2025, Barclays maintained coverage of RAPT Therapeutics (NasdaqGM:RAPT) with a Overweight ...

Fintel reports that on October 21, 2025, HC Wainwright & Co. reiterated coverage of Cidara Therapeutics (NasdaqCM:CDTX) with ...

Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...

Prosper Junior Bakiny has positions in Eli Lilly and Viking Therapeutics. The Motley Fool recommends Viking Therapeutics. The ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $5.62, a high estimate of $7.00, and a low estimate of $3.50. This current average has increased by 60.57% ...

Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a ...

Since then, supply has returned thanks to Lilly's investments in manufacturing and a move to also offer Zepbound, previously ...

Sionna Therapeutics said it started a Phase 2a proof-of-concept trial evaluating the results of SION-719, a nucleotide binding domain (NBD1) stabilizer, when added to Trikafta, which is the current ...

United Therapeutics (NASDAQ: UTHR) has outperformed the market over the past 15 years by 2.22% on an annualized basis producing an average annual return of 14.48%. Currently, United Therapeutics has a ...

Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small cap stocks with the highest upside. Janux Therapeutics, Inc.

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 17, Summit Therapeutics Inc.